Global Pharmacogenetics Testing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02256554

Publication Date:

March 3, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Pharmacogenetics Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Pharmacogenetics testing is a type of genetic testing that analyzes an individual"s genetic makeup to determine how they may respond to certain medications. It involves studying the variations in genes that affect drug metabolism, efficacy, and potential side effects.
Pharmacogenetics testing can provide valuable information to healthcare professionals in determining the most effective and safe medications for a particular individual. By understanding an individual"s genetic variations, doctors can tailor drug prescriptions to match their specific genetic profile, potentially improving treatment outcomes and reducing the risk of adverse drug reactions.
This type of testing is particularly useful in determining the appropriate dosage of medications, predicting the likelihood of adverse drug reactions, and identifying individuals who may be poor responders to certain drugs. It can also help avoid trial-and-error approaches to medication selection, allowing for more personalized and precise treatment plans.
Pharmacogenetics testing is commonly used in various medical fields, including psychiatry, cardiology, oncology, and pain management. It is especially beneficial for medications with a narrow therapeutic index, where small variations in drug metabolism can significantly impact treatment outcomes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淧harmacogenetics Testing Industry Forecast鈥� looks at past sales and reviews total world Pharmacogenetics Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmacogenetics Testing sales for 2025 through 2031. With Pharmacogenetics Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacogenetics Testing industry.
This Insight Report provides a comprehensive analysis of the global Pharmacogenetics Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmacogenetics Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmacogenetics Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacogenetics Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacogenetics Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacogenetics Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Dosage Selection
Adverse Reaction Assessment
Segmentation by Application:
Enterprise
Government
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genetworx
ARUP Laboratories
Labcorp
Invitae
Clinical Labs
Abomics
Gravity Diagnostics
Carolina Pharmacy
Kailos Genetics
Fulgent Genetics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmacogenetics Testing Market Size (2020-2031)
2.1.2 Pharmacogenetics Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmacogenetics Testing by Country/Region (2020, 2024 & 2031)
2.2 Pharmacogenetics Testing Segment by Type
2.2.1 Dosage Selection
2.2.2 Adverse Reaction Assessment
2.3 Pharmacogenetics Testing Market Size by Type
2.3.1 Pharmacogenetics Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmacogenetics Testing Market Size Market Share by Type (2020-2025)
2.4 Pharmacogenetics Testing Segment by Application
2.4.1 Enterprise
2.4.2 Government
2.5 Pharmacogenetics Testing Market Size by Application
2.5.1 Pharmacogenetics Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmacogenetics Testing Market Size Market Share by Application (2020-2025)
3 Pharmacogenetics Testing Market Size by Player
3.1 Pharmacogenetics Testing Market Size Market Share by Player
3.1.1 Global Pharmacogenetics Testing Revenue by Player (2020-2025)
3.1.2 Global Pharmacogenetics Testing Revenue Market Share by Player (2020-2025)
3.2 Global Pharmacogenetics Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmacogenetics Testing by Region
4.1 Pharmacogenetics Testing Market Size by Region (2020-2025)
4.2 Global Pharmacogenetics Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmacogenetics Testing Market Size Growth (2020-2025)
4.4 APAC Pharmacogenetics Testing Market Size Growth (2020-2025)
4.5 Europe Pharmacogenetics Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmacogenetics Testing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmacogenetics Testing Market Size by Country (2020-2025)
5.2 Americas Pharmacogenetics Testing Market Size by Type (2020-2025)
5.3 Americas Pharmacogenetics Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacogenetics Testing Market Size by Region (2020-2025)
6.2 APAC Pharmacogenetics Testing Market Size by Type (2020-2025)
6.3 APAC Pharmacogenetics Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmacogenetics Testing Market Size by Country (2020-2025)
7.2 Europe Pharmacogenetics Testing Market Size by Type (2020-2025)
7.3 Europe Pharmacogenetics Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmacogenetics Testing by Region (2020-2025)
8.2 Middle East & Africa Pharmacogenetics Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmacogenetics Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmacogenetics Testing Market Forecast
10.1 Global Pharmacogenetics Testing Forecast by Region (2026-2031)
10.1.1 Global Pharmacogenetics Testing Forecast by Region (2026-2031)
10.1.2 Americas Pharmacogenetics Testing Forecast
10.1.3 APAC Pharmacogenetics Testing Forecast
10.1.4 Europe Pharmacogenetics Testing Forecast
10.1.5 Middle East & Africa Pharmacogenetics Testing Forecast
10.2 Americas Pharmacogenetics Testing Forecast by Country (2026-2031)
10.2.1 United States Market Pharmacogenetics Testing Forecast
10.2.2 Canada Market Pharmacogenetics Testing Forecast
10.2.3 Mexico Market Pharmacogenetics Testing Forecast
10.2.4 Brazil Market Pharmacogenetics Testing Forecast
10.3 APAC Pharmacogenetics Testing Forecast by Region (2026-2031)
10.3.1 China Pharmacogenetics Testing Market Forecast
10.3.2 Japan Market Pharmacogenetics Testing Forecast
10.3.3 Korea Market Pharmacogenetics Testing Forecast
10.3.4 Southeast Asia Market Pharmacogenetics Testing Forecast
10.3.5 India Market Pharmacogenetics Testing Forecast
10.3.6 Australia Market Pharmacogenetics Testing Forecast
10.4 Europe Pharmacogenetics Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmacogenetics Testing Forecast
10.4.2 France Market Pharmacogenetics Testing Forecast
10.4.3 UK Market Pharmacogenetics Testing Forecast
10.4.4 Italy Market Pharmacogenetics Testing Forecast
10.4.5 Russia Market Pharmacogenetics Testing Forecast
10.5 Middle East & Africa Pharmacogenetics Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmacogenetics Testing Forecast
10.5.2 South Africa Market Pharmacogenetics Testing Forecast
10.5.3 Israel Market Pharmacogenetics Testing Forecast
10.5.4 Turkey Market Pharmacogenetics Testing Forecast
10.6 Global Pharmacogenetics Testing Forecast by Type (2026-2031)
10.7 Global Pharmacogenetics Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmacogenetics Testing Forecast
11 Key Players Analysis
11.1 Genetworx
11.1.1 Genetworx Company Information
11.1.2 Genetworx Pharmacogenetics Testing Product Offered
11.1.3 Genetworx Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Genetworx Main Business Overview
11.1.5 Genetworx Latest Developments
11.2 ARUP Laboratories
11.2.1 ARUP Laboratories Company Information
11.2.2 ARUP Laboratories Pharmacogenetics Testing Product Offered
11.2.3 ARUP Laboratories Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 ARUP Laboratories Main Business Overview
11.2.5 ARUP Laboratories Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Pharmacogenetics Testing Product Offered
11.3.3 Labcorp Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 Invitae
11.4.1 Invitae Company Information
11.4.2 Invitae Pharmacogenetics Testing Product Offered
11.4.3 Invitae Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Invitae Main Business Overview
11.4.5 Invitae Latest Developments
11.5 Clinical Labs
11.5.1 Clinical Labs Company Information
11.5.2 Clinical Labs Pharmacogenetics Testing Product Offered
11.5.3 Clinical Labs Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Clinical Labs Main Business Overview
11.5.5 Clinical Labs Latest Developments
11.6 Abomics
11.6.1 Abomics Company Information
11.6.2 Abomics Pharmacogenetics Testing Product Offered
11.6.3 Abomics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Abomics Main Business Overview
11.6.5 Abomics Latest Developments
11.7 Gravity Diagnostics
11.7.1 Gravity Diagnostics Company Information
11.7.2 Gravity Diagnostics Pharmacogenetics Testing Product Offered
11.7.3 Gravity Diagnostics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Gravity Diagnostics Main Business Overview
11.7.5 Gravity Diagnostics Latest Developments
11.8 Carolina Pharmacy
11.8.1 Carolina Pharmacy Company Information
11.8.2 Carolina Pharmacy Pharmacogenetics Testing Product Offered
11.8.3 Carolina Pharmacy Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Carolina Pharmacy Main Business Overview
11.8.5 Carolina Pharmacy Latest Developments
11.9 Kailos Genetics
11.9.1 Kailos Genetics Company Information
11.9.2 Kailos Genetics Pharmacogenetics Testing Product Offered
11.9.3 Kailos Genetics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Kailos Genetics Main Business Overview
11.9.5 Kailos Genetics Latest Developments
11.10 Fulgent Genetics
11.10.1 Fulgent Genetics Company Information
11.10.2 Fulgent Genetics Pharmacogenetics Testing Product Offered
11.10.3 Fulgent Genetics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Fulgent Genetics Main Business Overview
11.10.5 Fulgent Genetics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂